Holli Loomans-Kropp

Holli Loomans-Kropp is a prominent researcher from Ohio State University, known for leading a team that investigates the potential of metformin, a common diabetes medication, in complementing treatments for colon cancer, particularly those driven by the challenging KRAS gene mutations.